ADAPTIVE BIOTECHNOLOGIES CORPORATION Common Stock, Capital Shares Reserved for Future Issuance
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) had Common Stock, Capital Shares Reserved for Future Issuance of 64.99 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-04
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 64.99M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 45.77M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 44.00M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 45.20M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 64.99M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 45.77M shares 10-Q · filed 2026-05-05 |
| 2025-12-31 | 44.00M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 45.20M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 45.54M shares 10-Q · filed 2025-08-05 |
| 2025-03-31 | 45.86M shares 10-Q · filed 2025-05-01 |
| 2024-12-31 | 50.01M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 50.22M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 50.32M shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 50.41M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 43.99M shares 10-K · filed 2024-02-29 |
| 2023-09-30 | 44.30M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 44.43M shares 10-Q · filed 2023-08-02 |
| 2023-03-31 | 44.79M shares 10-Q · filed 2023-05-03 |
| 2022-12-31 | 37.38M shares 10-K · filed 2023-02-14 |
| 2022-09-30 | 37.50M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 37.70M shares 10-Q · filed 2022-08-03 |
| 2022-03-31 | 38.31M shares 10-Q · filed 2022-05-04 |
| 2021-12-31 | 39.09M shares 10-K · filed 2022-02-15 |
| 2021-09-30 | 39.46M shares 10-Q · filed 2021-11-03 |
| 2021-06-30 | 39.82M shares 10-Q · filed 2021-08-04 |
| 2021-03-31 | 40.60M shares 10-Q · filed 2021-05-05 |
| 2020-12-31 | 35.96M shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 37.22M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 38.17M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 39.79M shares 10-Q · filed 2020-05-12 |
| 2019-12-31 | 33.66M shares 10-K · filed 2020-02-26 |
| 2019-09-30 | 34.58M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 114.00M shares 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |